ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,436, issued on July 14, was assigned to Daewoong Pharmaceutical Co. Ltd. (Gyeonggi-do, South Korea).
"Pharmaceutical composition for preventing or treating fibrosis" was invented by Caroline Hee Lee (Seoul, South Korea), Min Jae Cho (Seoul, South Korea), Min Young Park (Seoul, South Korea), Ju Mi Han (Seoul, South Korea) and Joon Seok Park (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The pharmaceutical composition according to the present invention is used at specific therapeutic regimen and dosage, and can be usefully used for the prevention or treatment of fibrosis."
The patent was filed on May 2, 2022, under Application No....